BACKGROUND: Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate
cyclase, has been found to protect against reoxygenation-induced hypercontracture in …

Objectives: The aim of this investigation was to test whether the administration of atrial
natriuretic peptide (ANP) has cardioprotective effects against ischaemic and reperfusion …

OBJECTIVE: Human atrial natriuretic peptide has recently become known not only as a
heart failure drug but also for myocardial protection. We investigated its direct myocardial …

We investigated whether atrial natriuretic peptide (ANP) given just prior to reperfusion
reduces infarction in rabbit hearts and whether protection is related to activation of protein …

The aim of the present study was to examine the effects of atrial natriuretic peptide (ANP) on
the responses to coronary artery occlusion. In chloralose-urethane anaesthetised mongrel …

BACKGROUND: The serious shortage of organs for transplantation, especially lungs, has
drawn increasing attention to donation after cardiac death and protection of organs against …

The aim of this study is to investigate whether atrial natriuretic peptide can mimic
preconditioning to protect ischemia or reperfusion injury in rabbit hearts. New Zealand white …

We studied the effects of short-term global ischemia and reperfusion on ANP secretion from
Langendorff-perfused rat hearts compared with isolated ventricles. Effects of regional …

The effect of ischemia on atrial natriuretic peptide (ANP) release from heart ventricles was
studied by exposing the perfused hearts of Wistar-Kyoto (WKY) and spontaneously …

Acute coronary artery occlusion triggers the release of atrial natriuretic peptide (ANP) from
the heart. ANP affects vasodilation, natriuresis, and inflammation, but the integrated …